Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
3750 participants
OBSERVATIONAL
2017-10-16
2037-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-term Comparative Cerebrovascular Outcome After Transplantation vs Standard Care in Sickle Cell Anemia
NCT05053932
Early-goal Directed Automated Red Blood Cell Exchange for Acute Chest Syndrome in Sickle Cell Disease
NCT06214845
A GBT021601 ADME Microtracer Study in Healthy Volunteers
NCT05718687
POlycythemia, Proteins and ErYthropoiesis
NCT06905106
A Study of IMR-687 in Adult Participants With Sickle Cell Anemia (Homozygous HbSS or Sickle-β0 Thalassemia)
NCT03401112
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Affected patients
Biological samples of blood for all patients. Biological samples of saliva, surgical remainder (skin, tumor, kidney,....), saliva, urine, hair.
Biological sampling
Biological samples including blood, surgical remainder, urine,...
Non affected relatives
Biological samples of blood for all relatives.
Biological sampling
Biological samples including blood, surgical remainder, urine,...
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biological sampling
Biological samples including blood, surgical remainder, urine,...
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* For adult subjects, have signed an informed consent form,
* For minor or major under legal safeguard subjects, the form must be signed by both parents (for minors) or by the legal representative,
* Be affiliated to health insurance.
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Imagine Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olivier Hermine, MD, PhD
Role: STUDY_DIRECTOR
Assistance Publique - Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Hôpital de la Mère et de l'enfant Lagune
Cotonou, , Benin
CHU Amiens-Picardie
Amiens, , France
Hôpital Privé d'Antony
Antony, , France
Hôpital Avicenne
Bobigny, , France
Hôpital Pellegrin
Bordeaux, , France
Hôpital Beaujon
Clichy, , France
Hôpital Louis Mourier
Colombes, , France
Hopital Henri Mondor
Créteil, , France
CHU Kremlin Bicetre
Le Kremlin-Bicêtre, , France
Hopital de la conception
Marseille, , France
Hôpital d'Enfants de la TIMONE
Marseille, , France
Hôpital Saint Eloi
Montpellier, , France
CHU de Niort
Niort, , France
Groupe Hospitalier Diaconesses Croix Saint Simon
Paris, , France
Hopital Necker - Enfants malades
Paris, , France
Hôpital Armand Trousseau
Paris, , France
Hôpital Cochin
Paris, , France
Hôpital Européen Georges-Pompidou
Paris, , France
Hôpital Robert Debré
Paris, , France
Hôpital Saint Louis
Paris, , France
Hôpital Saint-Antoine
Paris, , France
Institut Pasteur
Paris, , France
CHU de Rouen
Rouen, , France
Hôpital national d'instruction des armées Bégin
Saint-Mandé, , France
CHU de la Guadeloupe
Pointe-à-Pitre, , Guadeloupe
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jules Alao, Pr
Role: primary
Alexandre Morel, Dr
Role: primary
Sébastien Larréché, Dr
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Qiang Y, Sissoko A, Liu ZL, Dong T, Zheng F, Kong F, Higgins JM, Karniadakis GE, Buffet PA, Suresh S, Dao M. Microfluidic study of retention and elimination of abnormal red blood cells by human spleen with implications for sickle cell disease. Proc Natl Acad Sci U S A. 2023 Feb 7;120(6):e2217607120. doi: 10.1073/pnas.2217607120. Epub 2023 Feb 2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IMNIS2015-04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.